TP53 and breast carcinoma: Mutation of the p53 gene or overexpression of its protein product has been identified in 14% to 52% of primary breast tumour specimens, and these alterations were found to be associated with poor prognosis in an analysis of more than 3,000 patients with primary breast cancer [10].